SS Innovations Surpasses Intuitive Surgical and Johnson & Johnson to Win Top Surgical Robotics Award

In a significant milestone for the surgical robotics industry, SS Innovations International, Inc. (NASDAQ: SSII) has been named the Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing finalists including Intuitive Surgical (NASDAQ: ISRG), Johnson & Johnson (NYSE: JNJ), and Medtronic (NYSE: MDT). The award recognizes a single company demonstrating excellence in innovation, commercial success, industry leadership, and positive societal impact. This achievement underscores SS Innovations' rapid emergence as a formidable competitor in the global surgical robotics market.

SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary "SSi Mantra" surgical robotic system and its comprehensive suite of "SSi Mudra" surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The award highlights the company's success in challenging established players like Intuitive Surgical, whose da Vinci system has long dominated the market, as well as Johnson & Johnson and Medtronic, which have invested heavily in robotic surgery platforms.

The recognition from the Surgical Robotics Industry Awards is particularly noteworthy given the caliber of the other finalists. Intuitive Surgical is the market leader with a significant installed base, while Johnson & Johnson and Medtronic are global medical device giants with extensive resources. SS Innovations' win suggests that its strategy of offering a more affordable and accessible system is resonating with healthcare providers and patients, especially in emerging markets. The company's SSi Mantra system is designed to reduce the cost of robotic surgery, potentially expanding access to millions of patients who currently cannot afford such procedures.

This announcement is important for investors and industry observers because it signals a potential shift in the competitive landscape of surgical robotics. SS Innovations' ability to outperform well-funded incumbents in an industry award points to the viability of its technology and business model. For more information about SS Innovations and its latest developments, visit the company's newsroom at https://ibn.fm/SSII.